Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
11 2021
Historique:
received: 03 02 2021
accepted: 26 05 2021
pubmed: 9 9 2021
medline: 26 3 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

Type 2 diabetes has been demonstrated to predispose to aortic valve calcification. We investigated whether type 2 diabetes concomitant to aortic stenosis (AS) enhances valvular inflammation and coagulation activation via upregulated expression of NF-κB, with subsequent increased expression of bone morphogenetic protein 2 (BMP-2). In this case-control study, 50 individuals with severe isolated AS and concomitant type 2 diabetes were compared with a control group of 100 individuals without diabetes. The median (IQR) duration of diabetes since diagnosis was 11 (7-18) years, and 36 (72%) individuals had HbA Diabetic compared with non-diabetic individuals displayed enhanced valvular expression of NF-κB, BMP-2, FII and FXa (all p ≤ 0.001). Moreover, the expression of NF-κB and BMP-2 positively correlated with amounts of valvular FII and FXa. Only in diabetic participants, valvular NF-κB expression was strongly associated with serum levels of HbA Type 2 diabetes enhances in loco inflammation and coagulation activation within stenotic valve leaflets. Increased valvular expression of NF-κB in diabetic individuals is associated not only with serum HbA

Identifiants

pubmed: 34494136
doi: 10.1007/s00125-021-05545-w
pii: 10.1007/s00125-021-05545-w
pmc: PMC8494674
doi:

Substances chimiques

BMP2 protein, human 0
Bone Morphogenetic Protein 2 0
NF-kappa B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2562-2574

Informations de copyright

© 2021. The Author(s).

Références

J Am Heart Assoc. 2017 May 5;6(5):
pubmed: 28476875
J Am Coll Cardiol. 2006 Feb 21;47(4):850-5
pubmed: 16487855
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Semin Immunopathol. 2012 Jan;34(1):133-49
pubmed: 21971685
Circ Cardiovasc Imaging. 2018 Mar;11(3):e007146
pubmed: 29555836
PLoS One. 2014 Dec 09;9(12):e114429
pubmed: 25490770
Circ Res. 2011 May 27;108(11):1392-412
pubmed: 21617136
J Fluoresc. 2015 Nov;25(6):1721-6
pubmed: 26410776
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):187-93
pubmed: 17975118
Thromb Haemost. 2011 Feb;105(2):254-60
pubmed: 21057695
J Mol Cell Cardiol. 2014 Jul;72:146-56
pubmed: 24631773
J Am Coll Cardiol. 2015 Aug 4;66(5):561-77
pubmed: 26227196
Circulation. 2018 Aug 7;138(6):590-599
pubmed: 29487139
Diab Vasc Dis Res. 2019 Jul;16(4):310-323
pubmed: 30623669
Thromb Haemost. 2015 Aug;114(2):217-27
pubmed: 25809537
Cardiovasc Diabetol. 2020 Jun 17;19(1):92
pubmed: 32552684
Ann Thorac Surg. 2018 Apr;105(4):1137-1143
pubmed: 29394992
Am J Cardiol. 2001 Sep 15;88(6):693-5
pubmed: 11564402
Trends Mol Med. 2008 Oct;14(10):429-40
pubmed: 18774340
Circulation. 2021 Feb 2;143(5):e72-e227
pubmed: 33332150
Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):105-7
pubmed: 17318769
Int J Cardiol. 2018 Jul 1;262:66-70
pubmed: 29605469
Inflammation. 2012 Jun;35(3):834-40
pubmed: 21935671
J Am Heart Assoc. 2020 Jul 7;9(13):e015261
pubmed: 32552251
Mol Med. 2015 Oct 27;21 Suppl 1:S32-40
pubmed: 26605646
J Cell Mol Med. 2020 Jun;24(11):6350-6361
pubmed: 32307869
Eur J Echocardiogr. 2009 Aug;10(6):723-5
pubmed: 19406839
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
Thromb Haemost. 2015 Nov;114(5):994-1003
pubmed: 26202300
Polymers (Basel). 2020 Nov 25;12(12):
pubmed: 33255639
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):638-655
pubmed: 31893948
Diabetologia. 2001 Feb;44(2):129-46
pubmed: 11270668
Circulation. 2006 May 2;113(17):2113-9
pubmed: 16636166
J Am Coll Cardiol. 2016 Jun 7;67(22):2565-74
pubmed: 27050187
Int J Cardiol. 2017 Oct 1;244:248-253
pubmed: 28684044
Int J Cardiol. 2009 Jun 12;135(1):4-13
pubmed: 19386374
Expert Rev Mol Med. 2009 Mar 12;11:e9
pubmed: 19278572
Vascul Pharmacol. 2020 Jul;130:106679
pubmed: 32387621
J Am Coll Cardiol. 1993 Apr;21(5):1220-5
pubmed: 8459080

Auteurs

Magdalena Kopytek (M)

John Paul II Hospital, Kraków, Poland.
Jagiellonian University Medical College, Kraków, Poland.

Piotr Mazur (P)

Jagiellonian University Medical College, Kraków, Poland.

Michał Ząbczyk (M)

John Paul II Hospital, Kraków, Poland.
Jagiellonian University Medical College, Kraków, Poland.

Anetta Undas (A)

John Paul II Hospital, Kraków, Poland.
Jagiellonian University Medical College, Kraków, Poland.

Joanna Natorska (J)

John Paul II Hospital, Kraków, Poland. j.natorska@szpitaljp2.krakow.pl.
Jagiellonian University Medical College, Kraków, Poland. j.natorska@szpitaljp2.krakow.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH